The intact human neuroblastoma cell (SH-SY5Y) exhibits high-affinity [3H]pirenzepine binding associated with hydrolysis of phosphatidylinositols
- PMID: 3361307
- DOI: 10.1111/j.1471-4159.1988.tb03038.x
The intact human neuroblastoma cell (SH-SY5Y) exhibits high-affinity [3H]pirenzepine binding associated with hydrolysis of phosphatidylinositols
Abstract
The binding of [3H]pirenzepine to a human neuroblastoma cell line (SH-SY5Y) and its correlation with hydrolysis of phosphatidylinositols were characterized. Specific [3H]pirenzepine binding to intact cells was rapid, reversible, saturable, and of high affinity. Kinetic studies yielded association (k+1) and dissociation (k-1) rate constants of 5.2 +/- 1.4 X 10(6) M-1 min-1 and 1.1 +/- 0.06 X 10(-1) min-1, respectively. Saturation experiments revealed a single class of binding sites (nH = 1.1) for the radioligand with a total binding capacity of 160 +/- 33 fmol/mg protein and an apparent dissociation constant of 13 nM. The specific [3H]pirenzepine binding was inhibited by the presence of selected muscarinic drugs. The order of antagonist potency was atropine sulfate greater than pirenzepine greater than AF-DX 116, with K0.5 of 0.53 nM, 2.2 nM, and 190 nM, respectively. The binding properties of [3H](-)-quinuclidinyl benzilate and its quaternary derivative [3H](-)-methylquinuclidinyl benzilate were also investigated. The muscarinic agonist carbachol stimulated formation of inositol phosphates which could be inhibited by muscarinic antagonists. The inhibition constants of pirenzepine and AF-DX 116 were 11 nM and 190 nM, respectively. In conclusion, we show that the nonclassical muscarinic receptor antagonist [3H]pirenzepine identifies a high-affinity population of muscarinic sites which is associated with hydrolysis of phosphatidylinositols in this human neuroblastoma cell line.
Similar articles
-
Muscarinic cholinergic ligand binding to intact mouse pituitary tumor cells (AtT-20/D16-16) coupling with two biochemical effectors: adenylate cyclase and phosphatidylinositol turnover.J Pharmacol Exp Ther. 1986 Mar;236(3):653-61. J Pharmacol Exp Ther. 1986. PMID: 3005550
-
Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain.J Pharmacol Exp Ther. 1990 Dec;255(3):1148-57. J Pharmacol Exp Ther. 1990. PMID: 2262898
-
[3H]AF-DX 116 labels subsets of muscarinic cholinergic receptors in rat brain and heart.Life Sci. 1987 Oct 5;41(14):1751-60. doi: 10.1016/0024-3205(87)90604-7. Life Sci. 1987. PMID: 3657382
-
Second-messenger responses associated with stimulation of neuronal muscarinic receptors expressed by a human neuroblastoma SH-SY5Y.Prog Brain Res. 1990;84:31-42. doi: 10.1016/s0079-6123(08)60886-9. Prog Brain Res. 1990. PMID: 2176302 Review. No abstract available.
-
Is there evidence of a role of the phosphoinositol-cycle in the myocardium?Mol Cell Biochem. 1989 Jun 27-Jul 24;88(1-2):65-72. doi: 10.1007/BF00223425. Mol Cell Biochem. 1989. PMID: 2550783 Review.
Cited by
-
Time-dependent effects of lithium on the agonist-stimulated accumulation of second messenger inositol 1,4,5-trisphosphate in SH-SY5Y human neuroblastoma cells.Biochem J. 1995 Oct 1;311 ( Pt 1)(Pt 1):225-32. doi: 10.1042/bj3110225. Biochem J. 1995. PMID: 7575458 Free PMC article.
-
Muscarinic (M1) receptor-mediated inhibition of K(+)-evoked [3H]-noradrenaline release from human neuroblastoma (SH-SY5Y) cells via inhibition of L- and N-type Ca2+ channels.Br J Pharmacol. 1994 Oct;113(2):621-7. doi: 10.1111/j.1476-5381.1994.tb17035.x. Br J Pharmacol. 1994. PMID: 7834216 Free PMC article.
-
PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site.Br J Pharmacol. 1989 Jul;97(3):914-20. doi: 10.1111/j.1476-5381.1989.tb12032.x. Br J Pharmacol. 1989. PMID: 2758243 Free PMC article.
-
Coupling of muscarinic receptors to the mobilization of intracellular Ca2+ stores in permeabilized SH-SY5Y human neuroblastoma cells.Biochem J. 1990 Nov 15;272(1):269-72. doi: 10.1042/bj2720269. Biochem J. 1990. PMID: 2264832 Free PMC article.
-
The interaction of parafluorohexahydrosiladiphenidol at muscarinic receptors in vitro.Br J Pharmacol. 1990 Apr;99(4):637-42. doi: 10.1111/j.1476-5381.1990.tb12983.x. Br J Pharmacol. 1990. PMID: 2361166 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous